• Pediatrics
• Pediatric Hematology-Oncology (Pediatrics)

• Assistant Professor of Pediatrics
• Director, Pediatric Neuro-Oncology Program

Brain and spinal cord tumors in childhood

Pediatric solid tumors

General Pediatric Hematology and Oncology

Development of clinical trials in brain and spinal cord tumors in childhood

Immunotherapy and cancer vaccines in Neuro-Oncology

• Erick Hernandez, Antonello Podda, George M. Zacur, Gennaro Selvaggi, Lesley Smith, Andreas G Tzakis, Tomoaki Kato, John Thompson. Multivisceral transplantation in a patient with unresectable hepatoblastoma. Third World congress of Pediatric Gastroenterology, Hepatology and Nutrition, WCPGHAN 3. Iguassu, Brazil. 08/2008.
• Podda A, Maciel M, Lewis, N, Barredo, J. Metachronous Intrasellar Mixed Germ Cell Tumor occurring four years after a mature teratoma of the pineal gland. Abstracts from the Thirteenth International Symposium on Pediatric Neuro-Oncology (ISPNO). Neuro-Oncology Vol 10-3, 2008
• Gary Kleiner, Julio Barredo, Sherry Shariatmadar, Aisha Khan, Rajendra Pahwas, Micahel Kritzer Cheren, Antonello Podda, Crisitna Fernandes, Ofelia Alvarez, Pable Rubinstein, Joanne Krutzburg. Succesful Combined Unrelated Umbilical Cord Blood Haploindentical Transplant in Non Malignant Disease. ASBMT/CIBMTR Tandem meetings, San Diego Ca, Feb 2008.
• Arroyo MR, Podda A, Cao D, Rodriguez MM. Placental Site Trophoblastic Tumor in the Ovary of a Young Child with Isosexual Precocious Puberty Pediatric and Developmental Pathology. Jul 08
• C. E. Fernandes, A. C. Schefler, T. G. Murray, J. A. Davis, O. A. Alvarez, A. Podda, J. C. Barredo, E. White, N. Lewis, S. R. Toledano. Chemotherapy plus cyclosporine A for the treatment of intraocular retinoblastoma: The University of Miami Miller School of Medicine experience. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (Jun 20 S), 2007: 20005
• Azouz EM, Saigal G, Rodriguez MM, Podda A. Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol. 2005 Feb;35(2):103-15. Epub 2004 Jul 28.
• Piva R, Liu J, Chiarle R, Podda A, Pagano M, Inghirami G. In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation. Mol Cell Biol. 2002 Dec;22(23):8375-87.
• Liu J; Piva R; Chiarle R; Podda A; Pagano M; Inghirami G. Cul1 and Skp1 complexes inactivation leads to defective chromosome segregation, genetic instability and neoplastic transformation. American journal of human genetics.2001;69:338
• Chiarle R, Podda A, Prolla G, Thorbecke GJ, Inghirami G. Costimulation of overexpressed CD30 enhances Th2 lymphokine expression in mature T cells. FASEB Journal 13 (4): A628-A628 Part 1 Suppl. S, MAR 12 1999
• Chiarle R, Podda A, Prolla G, Gong J, Thorbecke GJ, Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol. 1999 Feb;90(2):157-64.
• Chiarle R, Podda A, Prolla G, Podack ER, Thorbecke GJ, Inghirami G. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. J Immunol. 1999 Jul 1;163(1):194-205.
• Chiarle R, Podda A, Prolla G, Podack ER, Thorbecke GJ, Inghirami G. CD30 mediates thymic programmed cell death (PCD) through a BCL-2 sensitive pathway. FASEB Journal 12 (5): A930-A930 5386 Part 2 Suppl. S, MAR 20 1998
• Chiarle R, Podda A, Prolla G, Podack ER, Thorbecke GJ, Inghirami G. The murine CD30 antigen mediates thymocyte apoptosis through a BCL-2 dependent pathway. MODERN PATHOLOGY 11 (1): 126A-126A JAN 1998
• Chiarle R, Podda A, Prolla G, Podack ER, Thorbecke GJ, Inghirami G. CD30 mediates thymic negative selection through a NF-?B independent and Bcl-2 sensitive pathway. IX Meeting European Association for Haematopathology. Leiden-The Netherlands, 4/1998.
• Podda A, Galanello R, Maccioni L, Melis MA, Rosatelli C, Perseu L, Cao A. Hemoglobin Cagliari (beta 60 [E4] Val----Glu): a novel unstable thalassemic hemoglobinopathy. Blood. 1991 Jan 15;77(2):371-5.
• Cao A, Gasperini D, Podda A, Galanello R. Molecular Pathology of Thalassemia Intermedia. European Journal of Internal Medicine 1: 227-1990.
• Cao A, Loudianos G, Murru S, Podda A, Galanello R. Molecular basis of Atypical ?-Thalassemia. Advanced Course in Molecular Pathology and Biotechnology. Serono Symposia, Raven Press LTD, NY. Frati L. 1990. Publisher: Lippincott, Williams & Wilkins.
• Galanello R, Melis MA, Podda A, Monne M, Perseu L, Loudianos G, Cao A, Pirastu M, Piga A. Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome. Blood. 1990 Apr 15;75(8):1747-9.
• Galanello R, Podda A, Melis MA, Monne M, Cao A. Interaction between deletion delta-thalassemia and beta zero-thalassemia (codon 39 nonsense mutation) in a Sardinian family. Prog Clin Biol Res. 1989;316B:113-21.
• Podda A, Melis MA, Perseu L, Maccioni L, Ruggeri R, Addis M, Cao A, Galanello R. A new Unstable Hemoglobin Variant producing a Beta-Thalassemia like phenotype. 3rd International Conference on Thalassemias and Hemoglobinopathies. S. Margherita di Pula, Italy April, 1989
• Melis MA, Galanello R, Podda A, Monne M, Perseu L, Pirastu M, Cao A. Deletion ??-Thalassemia in a Sardinian family. 3rd International Conference on Thalassemias and Hemoglobinopathies. S. Margherita di Pula, Italy April 3-8, 1989.
• Monne M, Galanello R, Podda A, Melis MA, Paderi I, Macciotta A, Cao A. Non Deletion ?-Thalassemia Homozygosis (Codon 1 AUG?ACG). 5th Annual Scientific Meeting of Italian Society of Hematology. University of Sassari, Italy April 15, 1988.